1. Home
  2. YJ vs ENSC Comparison

YJ vs ENSC Comparison

Compare YJ & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YJ
  • ENSC
  • Stock Information
  • Founded
  • YJ 2015
  • ENSC 2003
  • Country
  • YJ China
  • ENSC United States
  • Employees
  • YJ N/A
  • ENSC N/A
  • Industry
  • YJ Other Specialty Stores
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • YJ Consumer Discretionary
  • ENSC Health Care
  • Exchange
  • YJ Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • YJ 8.8M
  • ENSC 7.9M
  • IPO Year
  • YJ 2019
  • ENSC N/A
  • Fundamental
  • Price
  • YJ $1.73
  • ENSC $6.07
  • Analyst Decision
  • YJ
  • ENSC
  • Analyst Count
  • YJ 0
  • ENSC 0
  • Target Price
  • YJ N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • YJ 40.5K
  • ENSC 56.1K
  • Earning Date
  • YJ 03-20-2025
  • ENSC 03-14-2025
  • Dividend Yield
  • YJ N/A
  • ENSC N/A
  • EPS Growth
  • YJ N/A
  • ENSC N/A
  • EPS
  • YJ N/A
  • ENSC N/A
  • Revenue
  • YJ $66,957,730.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • YJ N/A
  • ENSC $89.78
  • Revenue Next Year
  • YJ N/A
  • ENSC N/A
  • P/E Ratio
  • YJ N/A
  • ENSC N/A
  • Revenue Growth
  • YJ N/A
  • ENSC 40.41
  • 52 Week Low
  • YJ $1.42
  • ENSC $2.12
  • 52 Week High
  • YJ $4.72
  • ENSC $14.85
  • Technical
  • Relative Strength Index (RSI)
  • YJ 48.67
  • ENSC 40.88
  • Support Level
  • YJ $1.65
  • ENSC $5.34
  • Resistance Level
  • YJ $1.93
  • ENSC $6.46
  • Average True Range (ATR)
  • YJ 0.13
  • ENSC 0.49
  • MACD
  • YJ -0.01
  • ENSC -0.11
  • Stochastic Oscillator
  • YJ 28.57
  • ENSC 26.39

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: